Brief: Anika Names Cheryl R. Blanchard As President And CEO
April 27 (Reuters) - Anika Therapeutics Inc ANIK.O :
* ANIKA NAMES CHERYL R. BLANCHARD, PH.D., AS PRESIDENT AND
CHIEF
EXECUTIVE OFFICER
* ANIKA THERAPEUTICS INC - CHERYL R. BLANCHARD, HAS BEEN
NAMED
PRESIDENT AND CHIEF EXECUTIVE OFFICER, EFFECTIVE APRIL 26,2020
Source text for Eikon: ID:nBw5cwCRxa
Further company coverage: ANIK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anika Therapeutics
See all newsAnika Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Anika Therapeutics Q2 revenue rises, lifts 2026 outlook
Anika Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Anika Therapeutics Enters Fifth Amendment To Credit Agreement - SEC Filing
Anika Therapeutics Q1 revenue rises 13%